NextCure, Inc.(NXTC)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
NXTC has no upcoming report date in the calendar yet. It last reported on Nov 10, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±4.8%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 4 misses.
In plain words: it beat expectations 5 times, but the stock still fell 3 of those 5 times.
- May '26Beat▼ -4.1%
- Mar '26Beat▼ -2.9%
- Nov '25Beat▲ +2.0%
- Aug '25Missed▼ -4.4%
- May '25Beat▼ -7.7%
- Mar '25Missed▲ +5.2%
- Nov '24Missed▼ -2.3%
- Aug '24Missed▼ -0.6%
- Mar '24Beat▲ +19.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did NXTC fall after beating earnings?
4 of NXTC's last 9 reactions went against the EPS result. What stands out in each:
NXTC beat EPS estimates in 5 quarters, and the stock still closed lower the next day 3 times. In 3 of the 3 where we have price data, the stock had already run up before the report.
- May 7, 2026EPS beat +7.9%stock -4.1% next day
- It had risen 10.5% in the final week before the report, so good news may already have been priced in.
- Mar 5, 2026EPS beat +66.5%stock -2.9% next day
- It had risen 8.0% in the 20 trading sessions before the report, so good news may already have been priced in.
- May 1, 2025EPS beat +2.5%stock -7.7% next day
- It had risen 20.0% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.1% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 4)
- Mar 6, 2025EPS missed -13.9%stock +5.2% next day
- It had already fallen 10.7% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 4.1% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was NXTC's earnings move already priced in?
NXTC's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does NXTC hold its opening gap after earnings?
NXTC's opening move after each report and where it closed that day.
In 9 reports NXTC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 9 times (56%), and fully reversed 3 times. Gaps up faded 1 of 3; gaps down recovered 4 of 6.
- Nov 10, 2026FadedOpened -4.2%, closed 0.0%
- Aug 6, 2026ReversedOpened -5.7%, closed +4.5%
- Nov 5, 2025ReversedOpened -1.1%, closed +2.0%
- Aug 7, 2025HeldOpened -3.6%, closed -4.4%
- May 1, 2025HeldOpened -2.1%, closed -7.7%
- Mar 6, 2025HeldOpened +4.1%, closed +5.2%
- Nov 7, 2024ReversedOpened +2.2%, closed -2.3%
- Aug 1, 2024FadedOpened -5.0%, closed -0.6%
What the history says
- It fell after 3 of its 5 EPS beats (60%): beating estimates has not been enough on its own.
NXTC earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | After close | -$0.90 | -$0.90 | 0.0% | 0.00% | — |
| Aug 6, 2026 | After close | -$1.92 | -$1.85 | sources differ | +4.47% | +20.39% |
| May 7, 2026 | After close | -$2.03 | -$1.87 | +7.9% | -4.13% | -3.93% |
| Mar 5, 2026 | After close | -$2.42 | -$0.81 | +66.5% | -2.90% | -0.39% |
| Nov 5, 2025 | After close | -$3.98 | -$3.22 | +19.1% | +1.97% | -11.73% |
| Aug 7, 2025 | After close | -$4.61 | -$11.29 | -144.9% | -4.42% | -5.10% |
| May 1, 2025 | After close | -$4.80 | -$4.68 | +2.5% | -7.71% | -8.33% |
| Mar 6, 2025 | After close | -$4.32 | -$4.92 | -13.9% | +5.19% | -2.81% |
| Nov 7, 2024 | After close | -$3.84 | -$4.92 | -28.1% | -2.27% | +16.67% |
| Aug 1, 2024 | After close | -$4.95 | -$6.60 | -33.3% | -0.62% | -1.86% |
| May 2, 2024 | After close | -$5.52 | -$6.26 | -13.4% | — | — |
| Mar 21, 2024 | Before open | -$6.52 | -$6.24 | +4.3% | +19.15% | +41.13% |
NXTC Earnings FAQ
Answers computed from NextCure, Inc.'s reported history
NXTC has no upcoming report date in the calendar yet. It last reported on Nov 10, 2026; companies usually report every three months.
Over the last 11 quarters with a usable EPS surprise, NXTC beat the consensus estimate 5 times (46%), missed 5 and landed in line 1. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 11 quarters with a measured reaction, NXTC moved an average of ±4.8% in the first session after reporting. It closed higher 36% of the time; the largest gain was 19.2% and the largest drop -7.7%.
NXTC fell in the first session after 3 of its last 5 EPS beats (60%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, NXTC moved an average of +18.0% in the 20 trading sessions before reporting and was higher in 46% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -1.0%. After a drop of 3% or more (6 quarters), it rose the next day 33% of the time, averaging +2.3%. This describes past reports; it is not a forecast.
In 9 reports NXTC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 9 times (56%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · NXTC: 12 reported quarters, latest Nov 10, 2026. Information only, not investment advice.
Looking for more on NXTC?
Price charts, forecast, fundamentals and risk pages for NXTC are not on Tickzen yet. You can run a full stock analysis now.
Run the NXTC Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun